Compounds > carbamates

carbamates and glycolipids

carbamates has been researched along with glycolipids in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Akama, T; Arai, K; Goda, K; Kobori, T; Nishiguchi, M; Sugimoto, K; Suzuki, T; Taguchi, M; Takahashi, K; Tomishima, Y; Yamamoto, K1
Ashe, KM; Bangari, DS; Budman, E; Cheng, SH; Desnick, RJ; Leonard, JP; Marshall, J; Nietupski, JB; Scheule, RK; Siegel, CS; Wang, B1
Allaire, A; Bangari, DS; Budman, E; Cheng, SH; Cromwell, MA; Grabowski, GA; Leonard, JP; Marshall, J; Nietupski, JB; Park, H; Sun, Y; Wang, B1
Abuduaini, R; Bai, N; Wang, S; Zhang, M; Zhao, Y; Zhu, X1
Bao, Z; Fu, Z; Jin, Y; Lou, Z; Lu, H; Wu, A; Yu, Q; Zhao, Y1

Other Studies

5 other study(ies) available for carbamates and glycolipids

ArticleYear
Sphingomyelin analogues as inhibitors of sphingomyelinase.
    Bioorganic & medicinal chemistry letters, 2003, Jun-16, Volume: 13, Issue:12

    Topics: Animals; Brain; Carbamates; Inhibitory Concentration 50; Microsomes; Phosphodiesterase Inhibitors; Rats; Sphingomyelin Phosphodiesterase; Sphingomyelins; Structure-Activity Relationship

2003
Efficacy of Enzyme and Substrate Reduction Therapy with a Novel Antagonist of Glucosylceramide Synthase for Fabry Disease.
    Molecular medicine (Cambridge, Mass.), 2015, Apr-30, Volume: 21

    Topics: alpha-Galactosidase; Animals; Blood-Brain Barrier; Carbamates; Disease Models, Animal; Fabry Disease; Glucosyltransferases; Glycolipids; Humans; Mice; Quinuclidines; Sphingolipids; Trihexosylceramides

2015
CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2016, Volume: 24, Issue:6

    Topics: Administration, Oral; Animals; Carbamates; Central Nervous System; Disease Models, Animal; Enzyme Inhibitors; Gaucher Disease; Glucosyltransferases; Glycolipids; Humans; Inositol; Liver; Lysosomes; Mice; Quinuclidines; Tissue Distribution; Treatment Outcome

2016
Rhamnolipid-aided biodegradation of carbendazim by Rhodococcus sp. D-1: Characteristics, products, and phytotoxicity.
    The Science of the total environment, 2017, Jul-15, Volume: 590-591

    Topics: Benzimidazoles; Biodegradation, Environmental; Carbamates; Glycolipids; Rhodococcus; Surface-Active Agents

2017
Sub-chronic carbendazim exposure induces hepatic glycolipid metabolism disorder accompanied by gut microbiota dysbiosis in adult zebrafish (Daino rerio).
    The Science of the total environment, 2020, Oct-15, Volume: 739

    Topics: Animals; Benzimidazoles; Carbamates; Dysbiosis; Gastrointestinal Microbiome; Glycolipids; Lipid Metabolism; Male; RNA, Ribosomal, 16S; Zebrafish

2020